47.73.Z - Retail sale of pharmaceutical products
20 - Manufacture of chemicals and chemical products
46 - Wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
49 - Land transport and transport via pipelines
68 - Real estate activities
84.12.Z - Management of public services in health, education, culture, and other social services
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | -0,9 | 0,2 | 121,8 |
EBITDA | 0,1 | -0,9 | 0,2 | 126,2 |
Short time liabilities | 0,1 | 0 | 0 | -11,3 |
Equity capital | 2,1 | 0,9 | 0,9 | -4,3 |
Operating profit (EBIT) | -0 | -0,9 | 0,2 | 121,5 |
Assets | 2,1 | 1 | 0,9 | -4 |
Net profit (loss) | -0 | -0,9 | 0,2 | 121,8 |
Cash | 0,2 | 0,1 | 0,2 | 22,1 |
Net income from sale | 0,6 | 0,7 | 0,8 | 14,5 |
Liabilities and provisions for liabilities | 0,1 | 0 | 0 | 1 |
Working assets | 0,2 | 0,2 | 0,2 | -4,9 |
Depreciation | 0,1 | 0,1 | 0 | -53,9 |
% | % | % | p.p. | |
Profitability of capital | -0,6 | -102,4 | 23,3 | 125,7 |
Equity capital to total assets | 97,3 | 95,3 | 95,1 | -0,2 |
Gross profit margin | -2 | -140,9 | 26,8 | 167,7 |
EBITDA Margin | 13 | -131,9 | 30,2 | 162,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 31 | 23 | 18 | -5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane